Camurus AB (CAMRF)
61.75
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Camurus Profit Margin (Quarterly) : 34.30% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.30% |
| March 31, 2026 | 26.98% |
| December 31, 2025 | 21.72% |
| September 30, 2025 | 33.97% |
| June 30, 2025 | 36.24% |
| March 31, 2025 | 35.33% |
| December 31, 2024 | 26.57% |
| September 30, 2024 | 26.97% |
| June 30, 2024 | 16.68% |
| March 31, 2024 | 19.97% |
| December 31, 2023 | -4.06% |
| September 30, 2023 | 22.50% |
| June 30, 2023 | 44.70% |
| March 31, 2023 | 20.71% |
| December 31, 2022 | 4.88% |
| September 30, 2022 | 14.50% |
| June 30, 2022 | 3.63% |
| March 31, 2022 | -0.34% |
| December 31, 2021 | -7.67% |
| September 30, 2021 | -4.00% |
| June 30, 2021 | -35.09% |
| March 31, 2021 | -17.37% |
| December 31, 2020 | -62.02% |
| September 30, 2020 | -20.23% |
| Date | Value |
|---|---|
| June 30, 2020 | -24.68% |
| March 31, 2020 | -124.9% |
| December 31, 2019 | -205.2% |
| September 30, 2019 | -156.2% |
| June 30, 2019 | -735.7% |
| March 31, 2019 | -365.7% |
| December 31, 2018 | -1.12K% |
| September 30, 2018 | -223.7% |
| June 30, 2018 | -922.9% |
| March 31, 2018 | -247.8% |
| December 31, 2017 | -956.2% |
| September 30, 2017 | -418.0% |
| June 30, 2017 | -239.3% |
| March 31, 2017 | -234.1% |
| December 31, 2016 | -74.91% |
| September 30, 2016 | -43.28% |
| June 30, 2016 | -79.55% |
| March 31, 2016 | -95.90% |
| December 31, 2015 | -87.64% |
| September 30, 2015 | -61.07% |
| June 30, 2015 | -508.3% |
| March 31, 2015 | 17.45% |
| December 31, 2014 | 51.68% |
| September 30, 2014 | -4.57% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orexo AB | -2.93K% |
| Swedencare AB | 3.54% |
| Moberg Pharma AB | -56.91% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 20.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.08% |
| Return on Assets | 14.25% |
| Return on Invested Capital | 15.69% |
| Gross Profit Margin (Quarterly) | 92.70% |
| Operating Margin (Quarterly) | 42.80% |
| Return on Net Operating Assets | 74.73% |